Medical vs. Recreational Cannabis: Where Should I Invest?
Increasing your exposure to a variety of companies gives you the best chance to profit.
Increasing your exposure to a variety of companies gives you the best chance to profit.
In 2018, 4/20 marked the beginning of a blazing run for a number of cannabis companies.
Canopy Growth has secured the right to snatch up the largest MSO in the U.S. for a whopping $3.4 billion.
As each 4/20 comes and goes, the outlook for the cannabis sector gets brighter – not hazier. This year is one to celebrate.
Shares are their most volatile during earnings season, so it’s a great time to go bargain hunting or to book big gains.
Martha Stewart signed on as an advisor for Canopy Growth to create a line of CBD products for animals.
My team and I looked at cannabis companies’ revenue growth from last quarter… and the numbers are eye-popping.
Investors who embrace fundamentals and pay attention to valuations will eventually win.
Matthew shares which stocks are overpriced and which are ripe for the taking.
Matthew covers uplisting to major U.S. exchanges and the promising possibility of adult-use cannabis in New York.